Search - tctmd.com

Displaying 1 - 20 of 55

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News TCT 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

Todd Neale

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

Michael O'Riordan

October 10, 2024

News Conference News EuroPCR 2024

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

Caitlin E. Cox

May 16, 2024

News Daily News

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

L.A. McKeown

February 06, 2024

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Conference News ACC 2022

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

Todd Neale

April 03, 2022

News Daily News

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Yael L. Maxwell

January 27, 2022

News Daily News

Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles

Michael O'Riordan

May 12, 2021

News Daily News

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

Shelley Wood

February 16, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2020

Shelley Wood

October 30, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Conference News TCT 2019

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Yael L. Maxwell

October 08, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Michael O'Riordan

October 17, 2018

News Daily News

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Caitlin E. Cox

May 15, 2017

News Daily News

Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA

Caitlin E. Cox

October 18, 2016

News Daily News

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Michael O'Riordan

September 29, 2016

News Daily News

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

Todd Neale

September 19, 2016

Advertisement

TCTMD’s Top 10 Most Popular Stories for October 2025

Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions

What’s Going to Be Hot at TCT 2025

SCAI Releases Practical, Technical Advice for Primary PCI in STEMI

OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI

Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA

Add-on CMS Payment Sweetens Shockwave Choice, but Cost Still Rankles

FDA Approves Shockwave Intravascular Lithotripsy for Calcified Coronaries

TCTMD’s Top 10 Most Popular Stories for October 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show

Lipid-Rich Plaque in Nonculprit Regions of the Target Vessel Predicts Future MACE Risk

Calcium Supplements, but Not Dietary Calcium, Linked to Higher Long-term Risk of Atherosclerosis: MESA

Pharmacist Management of High Cholesterol Gets More Patients to Goal, Lowers LDL Levels: RxACT

Guerra de los Medios Británicos: BMJ, Lancet Siguen Recortando el Uso de Estatinas

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content